Terms: = Cervical cancer AND ARID1A, BAF250, 8289, ENSG00000117713, SMARCF1, C1orf4, BM029, B120, RP1-50O24_1, P270, BAF250a AND Clinical Outcome
294 results:
1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
2. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. Role of Lymphovascular Invasion in Oral Cavity Squamous Cell Carcinoma Regional Metastasis and Prognosis.
Moore AE; Alvi SA; Tarabichi O; Zhu VL; Buchakjian MR
Ann Otol Rhinol Laryngol; 2024 Mar; 133(3):300-306. PubMed ID: 37927046
[TBL] [Abstract] [Full Text] [Related]
5. Automated localization and segmentation of cervical lymph nodes on contrast-enhanced CT using a 3D foveal fully convolutional neural network.
Rinneburger M; Carolus H; Iuga AI; Weisthoff M; Lennartz S; Hokamp NG; Caldeira L; Shahzad R; Maintz D; Laqua FC; Baeßler B; Klinder T; Persigehl T
Eur Radiol Exp; 2023 Jul; 7(1):45. PubMed ID: 37505296
[TBL] [Abstract] [Full Text] [Related]
6. The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients.
Bolaños-Suárez V; Alfaro A; Espinosa AM; Medina-Martínez I; Juárez E; Villegas-Sepúlveda N; Gudiño-Zayas M; Gutiérrez-Castro A; Román-Bassaure E; Salinas-Nieves ME; Bruno-Muñoz S; Aranda C; Flores-Herrera O; Berumen J
Cancer Med; 2023 Jul; 12(14):15632-15649. PubMed ID: 37326348
[TBL] [Abstract] [Full Text] [Related]
7. The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
Song S; Han D; Zhang N; Mao Z; Guo X; Cheng G
Radiat Oncol; 2023 Mar; 18(1):46. PubMed ID: 36879287
[TBL] [Abstract] [Full Text] [Related]
8. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract] [Full Text] [Related]
9. Diffusion basis spectrum imaging predicts long-term clinical outcomes following surgery in cervical spondylotic myelopathy.
Zhang JK; Jayasekera D; Javeed S; Greenberg JK; Blum J; Dibble CF; Sun P; Song SK; Ray WZ
Spine J; 2023 Apr; 23(4):504-512. PubMed ID: 36509379
[TBL] [Abstract] [Full Text] [Related]
10. Differential Expression of RSK4 Transcript Isoforms in cancer and Its clinical Relevance.
Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy.
Im CM; Cho IJ; Yu HJ; Han B; Oh HH; Seo YJ; Kim KH; Myung DS; Cho SB; Lee WS; Nam TK; Joo YE
Anticancer Res; 2022 Dec; 42(12):5951-5959. PubMed ID: 36456158
[TBL] [Abstract] [Full Text] [Related]
12. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
13. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract] [Full Text] [Related]
14. The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose.
Kok HP; Herrera TD; Crezee J
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):994-1003. PubMed ID: 36288756
[TBL] [Abstract] [Full Text] [Related]
15. Epidemiology and Molecular Biology of HPV Variants in cervical cancer: The State of the Art in Mexico.
Muñoz-Bello JO; Carrillo-García A; Lizano M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955700
[TBL] [Abstract] [Full Text] [Related]
16. Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in cervical cancer.
Lang X; Huang C; Cui H
J Immunol Res; 2022; 2022():4954457. PubMed ID: 35942212
[TBL] [Abstract] [Full Text] [Related]
17. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
[TBL] [Abstract] [Full Text] [Related]
18. Influence of Grading on Management and outcome in Mucoepidermoid Carcinoma of the Parotid-A Multi-institutional Analysis.
Grasl S; Janik S; Faisal M; Grasl MC; Pammer J; Weinreb I; Fischer G; Kim J; Hosni A; de Almeida JR; Goldstein DP; Erovic BM
Laryngoscope; 2023 Jan; 133(1):124-132. PubMed ID: 35475580
[TBL] [Abstract] [Full Text] [Related]
19. clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience.
Kim MS; Jeong SY; Lee YY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Taiwan J Obstet Gynecol; 2022 Mar; 61(2):333-338. PubMed ID: 35361397
[TBL] [Abstract] [Full Text] [Related]
20. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
[TBL] [Abstract] [Full Text] [Related]
[Next]